Media reports on coronavirus (COVID-19) research by users of the APS is compiled here. If you know of articles not listed here please send the URL or link to apsinfo@anl.gov. (Note: No live coronaviruses are studied at the APS.)
WGN-TV, Interview with Stephen Streiffer, "New drug being considered in fight against COVID-19"
Voice of America" "US Lab Renowned for Nuclear Research Using High Tech to Fight COVID-19"
NBC 5 Chicago: "Inside Argonne National Laboratory’s High-Tech Effort To Crack The Code of COVID-19"
From Forbes: Moderna’s Announcement Was Great News - Just Not For The Reason You Think
From Physics Today: "World’s physics instruments turn their focus to COVID-19," includes quotes from Bob Fischetti, life sciences adviser at the APS; Lisa Keefe, executive director of IMCA-CAT; Andrzej Joachimiak, Director of the Structural Biology Center at the APS; Argonne Associate Lab Director and APS Director Stephen Streiffer
UChicago News: "Scientists hunt for antibodies, key in fight against coronavirus," includes quotes from Andrzej Joachimiak, Directoir of the Structural Biology Center at the APS, and Argonne Associate Lab Director and APS Director Stephen Streiffer
From Chicago Magazine: "The Chicago Scientists Trying to Save Our Lives"
WBBM-TV Chicago: "Argonne National Laboratory Uses Supercomputers To Take On Coronavirus"
From Northwestern University: "New Drug Target Found for COVID-19"
Facebook Live Interviews with Argonne COVID-19 Researchers
Naperville community tv: "Lawmakers Address Coronavirus Concerns"
Daily Herald: "Argonne scientists studying coronavirus proteins to seek treatment"
The WBEZ (Chicago public radio) interview with Karolina Michalska (SBC-XSD) can be accessed here.
The ABC-TV 7 interview can be viewed here (scroll down the page to find it).
The Fox 32 interview can be viewed here.
The NBC 5 interview can be viewed here.
The Chicago Tribune article, "Hunting for a coronavirus cure, scientists are mapping the proteins that cause COVID-19 at Argonne Lab," can be read here (subscription may be required).